Clínic Barcelona

Characterizing neovascular lesions on the macula allows us to predict the response to treatment in patients with AMD

A study coordinated by researchers at the Hospital Clínic-IDIBAPS reveals that characterizing the type of neovascular lesion in the eye of patients with age-related macular degeneration (AMD) allows us to establish a more accurate prognosis of the patient, predict what their response to treatment will be and personalize the care provided.

Javier Zarranz-Ventura, national coordinator of FRB Spain and senior researcher of the study (left), and Jordi Izquierdo-Serra, first author of the study.

Keep reading about:

Related news